ArticleCureus2025
Endovascular Repair of Abdominal Aortic and Iliac Aneurysms Complicated by Multiple Endoleaks, Renal Dysfunction, and Urological Interventions.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abdominal aortic aneurysm (AAA) is a serious vascular condition often treated with endovascular aneurysm repair (EVAR). While EVAR is less invasive than open surgery, it may lead to complications, particularly in patients with risk factors. Acute kidney injury (AKI), endoleaks, and ureteral obstruction are among the most severe. The uniqueness of this case lies in the rare coexistence of multiple severe complications - recurrent endoleaks, renal dysfunction, and irreversible urological damage, occurring together in a single patient. We present a case of a 61-year-old man with chronic kidney disease stage 4, atherosclerosis, atrial fibrillation, hypertension, and prior myocardial infarctions, who presented with abdominal aortic and iliac artery aneurysms. Initial EVAR with a bifurcated stent graft was successful. Three months later, complications began, including recurrent AKI, type IB and later type IA endoleak, type II endoleak, renal artery stent occlusion, hemorrhagic complications, and obstructive uropathy. Management included multiple reinterventions: nephrostomy placement, selective embolization, and relining of the renal artery stent via axillary access. Despite episodes of anuria and the need for dialysis, renal perfusion was partially restored following final stenting. Follow-up scintigraphy confirmed improved renal function. This case demonstrates the complexity of managing EVAR complications in patients with advanced renal dysfunction and systemic vascular disease. It underscores the importance of multidisciplinary care, early recognition of endoleaks, and proactive renal protection strategies to improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.